Aliskiren/amlodipine/hydrochlorothiazide

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Aliskiren/amlodipine/hydrochlorothiazide
Combination of
Aliskiren Renin inhibitor
Amlodipine Calcium channel blocker
Hydrochlorothiazide Diuretic
Clinical data
AHFS/Drugs.com Consumer Drug Information
License data
Pregnancy
category
  • US: D (Evidence of risk)
Routes of
administration
Oral
Legal status
Legal status
Identifiers
CAS Number 1486517-17-2
ATC code C09XA54 (WHO)
  (verify)

The drug combination aliskiren/amlodipine/hydrochlorothiazide (INNs, trade name Amturnide) is an antihypertensive approved by the U.S. Food and Drug Administration (FDA) on December 21, 2010.[1]

References[edit]

External links[edit]